Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The capsular polysaccharide of Neisseria meningitidis serogroup W-135 is a major virulence factor and a key target for active immunization against invasive meningococcal disease. Chemically, it is a repeating disaccharide polymer composed of galactose and sialic acid (N-acetylneuraminic acid) units, which can be variably O-acetylated. This capsule acts as a protective barrier for the bacterium, helping it evade host immune defenses, particularly complement-mediated killing and phagocytosis. However, when purified and administered as a vaccine antigen, either alone or conjugated to a carrier protein (such as diphtheria toxoid, CRM197, or tetanus toxoid), it stimulates the host's immune system to produce protective, complement-mediated bactericidal antibodies. These antibodies specifically recognize and bind to the serogroup W-135 capsule, facilitating bacterial opsonization, phagocytosis, and complement-mediated lysis. Vaccines targeting this polysaccharide, such as Menveo, MenQuadfi, Nimenrix, Penbraya, and Penmenvy, have been highly successful in reducing the incidence of meningitis and septicemia caused by serogroup W-135 Neisseria meningitidis.
Active immunization via stimulation of complement-mediated bactericidal antibody production and induction of T-cell dependent immune response when conjugated to a carrier protein.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis serogroup W-135 capsular polysaccharide (MenW-135 CPS).